1 May 2016 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Keratinocyte growth factor (KGF) is an epithelial mitogen that has been reported to protect the lungs from a variety of toxic and infectious insults. In prior studies we found that recombinant human KGF accelerates clearance of bacteria from the murine lung by augmenting the function of alveolar macrophages (AM). In this study we tested the hypothesis that endogenous KGF plays a role in the maintenance of innate pulmonary defense against gram-negative bacterial infections. KGF-deficient mice exhibited delayed clearance of Escherichia coli from the lungs, attenuated phagocytosis by AM, and decreased antimicrobial activity in bronchoalveolar lavage (BAL) fluid, due in part to reductions in levels of surfactant protein A, surfactant protein D, and lysozyme. These immune deficits were accompanied by lower alveolar type II epithelial cell counts and reduced alveolar type II epithelial cell expression of collectin and lysozyme genes on a per cell basis. No significant between-group differences were detected in selected inflammatory cytokines or BAL inflammatory cell populations at baseline or after bacterial challenge in the wild-type and KGF-deficient mice. A single intranasal dose of recombinant human KGF reversed defects in bacterial clearance, AM function, and BAL fluid antimicrobial activity. We conclude that KGF supports alveolar innate immune defense through maintenance of alveolar antimicrobial protein levels and functions of AM. Together these data demonstrate a role for endogenous KGF in maintenance of normal pulmonary innate immune function.
1 February 2025 in The Journal of Immunology
The erythroblastic island (EBI) functions as a niche in which erythroblastic island macrophages (EBIMφs) are positioned within rings of erythroblasts, providing support and signals that orchestrate efficient erythropoiesis. We postulated burn injury impacts the EBI niche, given the nearly universal presence of anemia and inflammation in burn patients, and a divergent myeloid transcriptional signature that we observed in murine bone marrow following burn injury, in which granulocyte colony-stimulating factor (G-CSF) secretion broadly attenuated the expression of EBIMφ marker genes. Notably, we identified the heme-induced transcription factor Spi-C as a robust marker of EBIMφs in Spicigfp/igfp mice. Two bone marrow cell populations, macrophages and Gr1-low monocytes, possessed cell-intrinsic Spic-GFP. Spic+ macrophages were distinguished by higher levels of green fluorescent protein, autofluorescence, F4/80, and CD163 while CD115 staining was negligible compared with Gr1-low monocytes. Application of Spicigfp/igfp mice in studies revealed a G-CSF–dependent reduction of Spic+ macrophages in postburn marrow, which coincided with a loss of erythroid cells and that G-CSF administration was sufficient to reduce Spic+ macrophages in the marrow. These results provide the first evidence that burn injuries impact the EBI niche through G-CSF–dependent reduction of Spic+ EBIMφs and support the use of Spicigfp/igfp mice in investigation of EBIMφs.
29 October 2026 in The FASEB Journal
COChristopher J. O'COnnell
+2
The pathology of concomitant burn and traumatic brain injury remains poorly defined, despite their frequent co‐occurrence in military settings and the potential for deleterious synergy. To address this gap, we combined established models of blast‐induced mild traumatic brain injury and 15% total body surface area flame burn to approximate a common combat‐related trauma and examined how the injuries interact to shape systemic inflammation and brain transcriptional programs. Burn injury induced systemic G‐CSF and IL‐6 secretion and hematopoietic reprioritization, whereas overlapping brain injury did not substantially alter these systemic effects but magnified brain transcriptional responses relative to single injuries. Bulk RNA‐seq profiling at 6 h post‐injury revealed enriched gene sets associated with inflammation and endocrine stress in the combined injury group, alongside elevated systemic cytokines and corticosterone; thereby suggesting concurrent immune‐endocrine activation. Since our prior work demonstrated burn wound‐associated IL‐1 signaling induces G‐CSF and IL‐6 secretion, we tested IL‐1 neutralizing antibodies and anakinra as therapies. Treatment reduced G‐CSF and IL‐6 secretion, improved erythropoiesis, and selectively modulated brain transcriptional changes. Single‐nucleus RNA‐seq projection mapping predicted that the transcripts altered by combined injury were broadly enriched across vascular and glial cell types. Targeted expression profiling identified a shared brain‐liver signature characterized by an IL‐1/6‐dependent inflammatory response alongside an interleukin‐independent stress response. These findings highlight IL‐1‐responsive inflammatory signals and endocrine stress interactions within a multi‐organ network that shapes the early brain transcriptional response to the combined injury.